Bond.az White LogoBond.az Black Logo

KeyBanc Reiterates Overweight on Walmart, $145 Target

KeyBanc reiterates Overweight on Walmart with $145 target. Walmart shows strong market share gains and digital momentum despite recent stock decline.

John Smith
ByJohn Smith- Senior Editor
|
0

KeyBanc reiterated an Overweight rating on Walmart (NYSE:WMT) with a $145.00 price target, citing the retailer's continued market share gains and digital momentum.

Walmart reported first-quarter earnings per share above guidance despite headwinds. The company gained market share in grocery and general merchandise across all income cohorts. Despite strong fundamentals, shares have declined 7.7% over the past week, trading at $121.34.

Second-quarter guidance came in below expectations. KeyBanc believes Walmart is positioned to continue gaining share and offset rising transportation costs. The firm revised its estimates and named Walmart a top pick.

Analyst Bradley Thomas noted Walmart's share gains and digital flywheel have strong momentum. The company has raised its dividend for 31 consecutive years.

In other news, Walmart reported Q1 FY2027 revenue of $177.8 billion, beating estimates by $2.97 billion. Freedom Broker upgraded Walmart to hold from sell with a $133 target. RBC Capital lowered its target to $137 but maintained Outperform. Truist Securities raised its target to $140.

More News
Today / 12:23
|
531

Cantor Fitzgerald Reiterates Workday Rating on AI Growth

Cantor Fitzgerald reaffirms Workday Overweight rating, highlighting AI growth. Stock at $121.85, target $160.

0
Today / 12:21
|
379

Cantor Reiterates Overweight on ORIC Stock

Cantor Fitzgerald reiterated Overweight on ORIC Pharmaceuticals. Pfizer trial results and analyst ratings update.

0
Today / 12:20
|
278

Summit Therapeutics Analysis: Cantor Fitzgerald Backs Overweight

Cantor Fitzgerald reiterates Overweight on Summit Therapeutics. HARMONi-3 trial miss and analyst views covered by Bond.az.

0
Today / 12:13
|
680

Stifel reiterates IBM Buy after $1bn Chips Act award

Stifel reiterates IBM Buy rating after $1bn Chips Act award for quantum computing. Stock up 15%.

0
Today / 12:12
|
688

Stifel Maintains Buy on Deckers Outdoor at $140

Stifel reiterates Buy rating on Deckers Outdoor with $140 target. Stock shows strong growth potential and attractive valuation.

0
Today / 12:11
|
286

Argus Upgrades CAVA Group Stock Rating

Argus upgraded CAVA Group to Buy with a $92 target, citing improved restaurant traffic. Stock returned 66% in six months.

0
Today / 12:03
|
516

BofA raises Zoom price target on strong margins

BofA Securities raised Zoom's price target to $105, citing strong margins and free cash flow after Q1 results beat expectations.

0
Today / 11:53
|
249

Workday price target cut by Needham

Needham cuts Workday price target to $180 from $300, maintaining Buy rating. Workday beats revenue and income estimates, raises operating guidance.

0
Today / 11:53
|
473

BioMarin Neutral Rating, $50 Target by HC Wainwright

H.C. Wainwright reiterates Neutral on BioMarin with $50 target after Phase 3 hypochondroplasia results. Stock at $54.10, competitive landscape analyzed.

0
Today / 11:41
|
877

Summit Therapeutics downgraded to neutral

H.C. Wainwright downgrades Summit Therapeutics to Neutral due to competitive pressure from Merck.

0
Today / 11:21
|
610

RBC Capital Initiates Essent Group at Sector Perform

RBC Capital starts Essent Group with Sector Perform, $68 target. Limited earnings growth expected through 2028, with ROE below 12%.

0
Today / 11:02
|
586

Dell Stock Rises on AI Momentum

Evercore ISI reaffirms Dell Outperform on AI momentum. Dell stock up 102% YTD, AI factory serves 5,000+ customers. New products unveiled.

0
...
KeyBanc Reiterates Overweight on Walmart, $145 Target | Bond.az